These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 33038001)
1. A retrospective chart review study of symptom onset, diagnosis, comorbidities, and treatment in patients with binge eating disorder in Canadian clinical practice. Gill SK; Kaplan AS Eat Weight Disord; 2021 May; 26(4):1233-1242. PubMed ID: 33038001 [TBL] [Abstract][Full Text] [Related]
3. Exploring bi-directional impacts of Lisdexamfetamine dimesylate on psychological comorbidities and quality of life in people with Binge Eating Disorder. Griffiths KR; Boulet S; Barakat S; Touyz S; Hay P; Maguire S; Kohn MR J Eat Disord; 2024 Jun; 12(1):80. PubMed ID: 38872181 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of Lisdexamfetamine in Adults With Moderate to Severe Binge-Eating Disorder: A Randomized Clinical Trial. Hudson JI; McElroy SL; Ferreira-Cornwell MC; Radewonuk J; Gasior M JAMA Psychiatry; 2017 Sep; 74(9):903-910. PubMed ID: 28700805 [TBL] [Abstract][Full Text] [Related]
5. Time course of the effects of lisdexamfetamine dimesylate in two phase 3, randomized, double-blind, placebo-controlled trials in adults with binge-eating disorder. McElroy SL; Hudson JI; Gasior M; Herman BK; Radewonuk J; Wilfley D; Busner J Int J Eat Disord; 2017 Aug; 50(8):884-892. PubMed ID: 28481434 [TBL] [Abstract][Full Text] [Related]
7. Treatment characteristics among patients with binge-eating disorder: an electronic health records analysis. Spalding WM; Bertoia ML; Bulik CM; Seeger JD Postgrad Med; 2023 Apr; 135(3):254-264. PubMed ID: 35037815 [TBL] [Abstract][Full Text] [Related]
8. Lisdexamfetamine for binge eating disorder in adults: a systematic review of the efficacy and safety profile for this newly approved indication - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed? Citrome L Int J Clin Pract; 2015 Apr; 69(4):410-21. PubMed ID: 25752762 [TBL] [Abstract][Full Text] [Related]
9. Lisdexamfetamine dimesylate in binge eating disorder: a placebo controlled trial. Guerdjikova AI; Mori N; Blom TJ; Keck PE; Williams SL; Welge JA; McElroy SL Hum Psychopharmacol; 2016 Sep; 31(5):382-91. PubMed ID: 27650406 [TBL] [Abstract][Full Text] [Related]
10. Clinical Characteristics and Treatment Response to Lisdexamfetamine Dimesylate Versus Placebo in Adults With Binge Eating Disorder: Analysis by Gender and Age. Kornstein SG; Bliss C; Kando J; Madhoo M J Clin Psychiatry; 2019 Feb; 80(2):. PubMed ID: 30817099 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial. McElroy SL; Hudson JI; Mitchell JE; Wilfley D; Ferreira-Cornwell MC; Gao J; Wang J; Whitaker T; Jonas J; Gasior M JAMA Psychiatry; 2015 Mar; 72(3):235-46. PubMed ID: 25587645 [TBL] [Abstract][Full Text] [Related]
12. Lisdexamfetamine Dimesylate Effects on Binge Eating Behaviour and Obsessive-Compulsive and Impulsive Features in Adults with Binge Eating Disorder. McElroy SL; Mitchell JE; Wilfley D; Gasior M; Ferreira-Cornwell MC; McKay M; Wang J; Whitaker T; Hudson JI Eur Eat Disord Rev; 2016 May; 24(3):223-31. PubMed ID: 26621156 [TBL] [Abstract][Full Text] [Related]
13. The patient experience with DSM-5-defined binge eating disorder: characteristics, barriers to treatment, and implications for primary care physicians. Herman BK; Safikhani S; Hengerer D; Atkins N; Kim A; Cassidy D; Babcock T; Agus S; Lenderking WR Postgrad Med; 2014 Sep; 126(5):52-63. PubMed ID: 25295650 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological treatment of binge eating disorder: update review and synthesis. Reas DL; Grilo CM Expert Opin Pharmacother; 2015; 16(10):1463-78. PubMed ID: 26044518 [TBL] [Abstract][Full Text] [Related]
17. Comparing men and women with binge-eating disorder and co-morbid obesity. Lydecker JA; Grilo CM Int J Eat Disord; 2018 May; 51(5):411-417. PubMed ID: 29493793 [TBL] [Abstract][Full Text] [Related]
18. Effect of lisdexamfetamine on emotional network brain dysfunction in binge eating disorder. Fleck DE; Eliassen JC; Guerdjikova AI; Mori N; Williams S; Blom TJ; Beckwith T; Tallman MJ; Adler CM; DelBello MP; Strakowski SM; McElroy SL Psychiatry Res Neuroimaging; 2019 Apr; 286():53-59. PubMed ID: 30903953 [TBL] [Abstract][Full Text] [Related]
19. A psychometric analysis and revalidation of the Yale-Brown Obsessive Compulsive Scale modified for Binge Eating in adults with binge eating disorder. Yee K; Serrano D; Kando J; McElroy SL Qual Life Res; 2019 Dec; 28(12):3385-3394. PubMed ID: 31473907 [TBL] [Abstract][Full Text] [Related]
20. Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase 3 Randomized Controlled Trials. McElroy SL; Hudson J; Ferreira-Cornwell MC; Radewonuk J; Whitaker T; Gasior M Neuropsychopharmacology; 2016 Apr; 41(5):1251-60. PubMed ID: 26346638 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]